GlassScriptPhysician profile
Roger B Reed
NPI 1548252224
$3,336.47
in general payments reported to CMS, 2019-2025
28 companies · $65.50 in 2025
The $65.50 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $130 · 2021: $372 · 2022: $723 · 2023: $472 · 2024: $912 · 2025: $65.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,449.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $783.39 | 2022-2024 | |
| Organogenesis INC. | $341.77 | 2019-2024 | Puraply |
| Bioventus LLC | $293.60 | 2019-2024 | Exogen Ultrasound Bone Healing System, Durolane, Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $281.84 | 2019-2024 | Collagenase Santyl |
| Goode Surgical INC | $189.39 | 2019-2023 | |
| Alafair Biosciences, INC. | $177.25 | 2024 | Versawrap |
| Nevro Corp. | $172.19 | 2022-2023 | Senza |
| Avita Medical Americas, LLC | $143.05 | 2024 | |
| Tactile Systems Technology INC | $125.61 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Stryker Corporation | $102.11 | 2021-2022 | |
| Horizon Therapeutics Plc | $96.27 | 2019-2022 | |
| Abbott Laboratories | $95.48 | 2023-2024 | Proclaim |
| Rikco International, LLC | $88.00 | 2019 | |
| Amgen INC. | $51.85 | 2024 | Krystexxa |
| Grt US Holding, INC. | $48.06 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $45.31 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Solventum Corporation | $42.40 | 2024 | V.A.C. Veraflo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.61 | 2021-2022 | |
| Pinnacle Transplant Technologies, LLC | $38.70 | 2020 | |
| Merck Sharp & Dohme LLC | $35.52 | 2019 | |
| Averitas Pharma INC. | $33.75 | 2023-2024 | Qutenza |
| Curonix LLC | $20.19 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Zimmer Biomet Holdings, INC. | $19.54 | 2020 | |
| Next Science LLC | $17.22 | 2023 | Surgx, Blastx, Xperience |
| Paratek Pharmaceuticals, INC. | $17.11 | 2024 | Nuzyra |
| Osiris Therapeutics INC. | $15.29 | 2019 | |
| Orthofix Medical, INC. | $11.67 | 2020 | |
| Cardiovascular Systems INC. | $10.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.